B. Riley Wealth Management, Inc. - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.

Quarter-by-quarter ownership
B. Riley Wealth Management, Inc. ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q1 2022$271,000
-1.1%
6,226
+0.4%
0.02%
+10.5%
Q4 2021$274,000
+16.1%
6,204
+0.4%
0.02%
+5.6%
Q3 2021$236,000
-21.1%
6,179
-17.6%
0.02%
-45.5%
Q2 2021$299,000
-16.9%
7,500
-25.6%
0.03%
-21.4%
Q1 2021$360,000
-18.6%
10,081
-16.1%
0.04%
-26.3%
Q4 2020$442,000
-32.0%
12,011
-30.5%
0.06%
-26.0%
Q3 2020$650,000
+8.3%
17,279
+17.4%
0.08%
+16.7%
Q2 2020$600,000
-8.8%
14,715
-15.3%
0.07%
-4.3%
Q1 2020$658,000
+41.8%
17,370
+76.0%
0.07%
-1.4%
Q4 2019$464,000
-10.3%
9,867
-18.6%
0.07%
-22.2%
Q3 2019$517,000
+3.0%
12,118
-3.3%
0.09%
+16.9%
Q2 2019$502,000
-15.2%
12,538
-11.5%
0.08%
-25.2%
Q1 2019$592,000
+35.5%
14,168
+24.0%
0.10%
+12.0%
Q4 2018$437,000
+7.1%
11,426
+12.4%
0.09%
-8.0%
Q3 2018$408,000
+170.2%
10,166
+179.5%
0.10%
-16.7%
Q2 2015$151,000
-37.3%
3,637
-30.4%
0.12%
-33.7%
Q1 2015$241,000
+8.6%
5,222
+0.5%
0.18%
-0.5%
Q4 2014$222,000
+62.0%
5,197
+74.2%
0.18%
+78.4%
Q3 2014$137,000
+13.2%
2,983
+31.5%
0.10%
+30.8%
Q2 2014$121,000
+80.6%
2,268
+81.4%
0.08%
+59.2%
Q1 2014$67,0001,2500.05%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q4 2020
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 100,000$3,680,00012.40%
Black Creek Investment Management Inc. 7,443,061$273,905,0008.54%
KAHN BROTHERS GROUP INC 1,281,924$47,174,803,0008.23%
Camber Capital Management LP 3,500,000$128,800,0004.52%
Eversept Partners, LP 946,581$35,196,5224.13%
EQUITY INVESTMENT CORP 2,321,164$85,419,0003.98%
Galibier Capital Management Ltd. 575,741$21,187,0003.66%
Keystone Financial Planning, Inc. 217,399$8,000,0003.32%
CLIFFORD CAPITAL PARTNERS LLC 217,817$8,016,0003.14%
CLARK ESTATES INC/NY 485,000$17,848,0002.52%
View complete list of GLAXOSMITHKLINE PLC shareholders